Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 672 entries
View as:

Safety, Pharmacodynamics, Pharmacokinetics, and Efficacy of GS-9901 in Adults With Relapsed or Refractory Follicular Lymphoma, Marginal Zone Lymphoma, Chronic Lymphocytic Leukemia, or Small Lymphocytic Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT02258555 Org: User:
Start: 01/31/15 End: 08/31/15 Due: 08/31/16

Idelalisib in Combination With Rituximab for Previously Untreated Follicular Lymphoma and Small Lymphocytic Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT02258529 Org: User:
Start: 09/14/15 End: 05/03/16 Due: 05/03/17

A Registry for Adolescent and Pediatric Participants Who Received a Gilead Hepatitis C Virus Direct Acting Antiviral (DAA) in Gilead-Sponsored Chronic Hepatitis C Infection Trials

Phase: N/A Priority: Normal
NCT ID: NCT02510300 Org: User:
Start: 10/21/15 End: 01/06/23 Due: 01/06/24

Phase 2 Extension Study of Ambrisentan in Pulmonary Arterial Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00424021 Org: User:
Start: 04/30/03 End: 12/31/09 Due: 12/31/10

Study to Evaluate Organic Anion Transporting Polypeptide (OATP) Transporter-Mediated Drug-Drug Interactions Between Filgotinib and Statins as Probe Drugs in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT04608344 Org: User:
Start: 11/04/20 End: 01/13/21 Due: 01/13/22

Study of BSF 208075 Evaluating Exercise Capacity in Patients With Pulmonary Arterial Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00046319 Org: User:
Start: 09/30/02 End: 06/30/03 Due: 06/30/04

Evaluate Efficacy, Safety and PK of Adefovir Dipivoxil Liquid Suspension in Patients With Chronic Hepatitis B

Phase: N/A Priority: Normal
NCT ID: NCT00071201 Org: User:
Start: 06/30/03 End: 03/31/06 Due: 03/31/07

Study to Evaluate the Safety and Efficacy of the Combination of Tirabrutinib and Idelalisib With and Without Obinutuzumab in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

Phase: N/A Priority: Normal
NCT ID: NCT02968563 Org: User:
Start: 12/13/16 End: 01/14/21 Due: 01/14/22

(ARTEMIS-IPF) Randomized, Placebo-Controlled Study to Evaluate Safety and Effectiveness of Ambrisentan in IPF

Phase: N/A Priority: Normal
NCT ID: NCT00768300 Org: User:
Start: 12/31/08 End: 02/28/11 Due: 02/28/12

A Phase 1b Study Assessing GS-7340 in Treatment-Naive Adults With Chronic Hepatitis B

Phase: N/A Priority: Normal
NCT ID: NCT01671787 Org: User:
Start: 03/31/12 End: 04/30/13 Due: 04/30/14

A Study of Cidofovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS

Phase: N/A Priority: Normal
NCT ID: NCT00002384 Org: User:
Start: - End: - Due: -

Study of Sacituzumab Govitecan Versus Physician's Choice of Treatment in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread

Phase: N/A Priority: Normal
NCT ID: NCT04527991 Org: User:
Start: 01/13/21 End: 10/31/25 Due: 10/31/26

Sofosbuvir and Ribavirin in Treatment-Naive and Treatment-Experienced Subjects With Chronic Genotype 2 or 3 HCV Infection

Phase: N/A Priority: Normal
NCT ID: NCT01682720 Org: User:
Start: 09/30/12 End: 01/31/14 Due: 01/31/15

Study of Obeldesivir in Nonhospitalized Participants With COVID-19

Phase: N/A Priority: Normal
NCT ID: NCT05715528 Org: User:
Start: 02/08/23 End: 01/23/24 Due: 01/23/25

Radiolabeled Monoclonal Antibody in the Detection and Staging of Patients With Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00003337 Org: User:
Start: 03/31/97 End: - Due: -

Study of Magrolimab in Patients With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT04827576 Org: User:
Start: 10/01/21 End: 10/01/24 Due: 10/01/25

Study of Sacituzumab Govitecan in Participants With Advanced or Metastatic Solid Tumor and Moderate Liver Impairment

Phase: N/A Priority: Normal
NCT ID: NCT04617522 Org: User:
Start: 04/06/21 End: 12/31/26 Due: 12/31/27

Expanded Access for Bulevirtide

Phase: N/A Priority: Normal
NCT ID: NCT06780579 Org: User:
Start: - End: - Due: -

Study of GS-4528 in Adults With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT05840224 Org: User:
Start: 05/11/23 End: 12/31/25 Due: 12/31/26

SOF (Sovaldi®) +RBV for 16 or 24 Weeks and SOF+RBV+Peg-IFN for 12 Weeks in Adults With Genotype 2 or 3 Chronic HCV Infection

Phase: N/A Priority: Normal
NCT ID: NCT01962441 Org: User:
Start: 09/24/13 End: 07/07/16 Due: 07/07/17

Pharmacokinetics of Voxilaprevir in Adults With Normal Hepatic Function and Moderate or Severe Hepatic Impairment

Phase: N/A Priority: Normal
NCT ID: NCT02397707 Org: User:
Start: 03/24/15 End: 03/04/16 Due: 03/04/17

Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination (FDC) and Sofosbuvir/Velpatasvir FDC and Ribavirin in Participants With Chronic Genotype 3 HCV Infection and Cirrhosis

Phase: N/A Priority: Normal
NCT ID: NCT02781558 Org: User:
Start: 07/29/16 End: 10/27/17 Due: 10/27/18

Tenofovir DF (Disoproxil Fumarate) in Combination With Emtricitabine in HIV-1 Patients

Phase: N/A Priority: Normal
NCT ID: NCT00106379 Org: User:
Start: 10/31/04 End: 01/31/07 Due: 01/31/08

Study to Evaluate the Effect of Ranolazine and Dronedarone When Given Alone and in Combination in Patients With Paroxysmal Atrial Fibrillation

Phase: N/A Priority: Normal
NCT ID: NCT01522651 Org: User:
Start: 01/24/12 End: 03/10/14 Due: 03/10/15

Study to Evaluate Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Fixed Dose Combination (FDC) in Virologically-Suppressed HIV-1 Infected Adults Harboring the Archived Isolated NRTI Resistance Mutation M184V/M184I

Phase: N/A Priority: Normal
NCT ID: NCT02616029 Org: User:
Start: 12/17/15 End: 07/11/19 Due: 07/11/20